CNC vs IPCXR · P/E 8.4, rev $103.52B vs rev $100.0M
Centene Corp (CNC) versus Inflection Point Acquisition Corp. III Rights (IPCXR) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. IPCXR currently screens at market cap $0.
Not investment advice. Open the CNC and IPCXR stock pages for the full models.
Not investment advice.